Skip to main content
. 2022 Jun 28;13:873315. doi: 10.3389/fimmu.2022.873315

Figure 6.

Figure 6

Involvement of B cell survival receptor expression in post-SCI immunity. Percentages (A) and median fluorescence intensity (MFI) (B) of B cells expressing BAFFR, TACI and CD74 are shown within the B cell population of HC (n = 18) and SCI patients (n = 18), including (s)aSCI (17 samples) and cSCI (29 samples). Mean (bars) ± SD is depicted and shown in numbers. Percentages (C) and MFI (D) of CD74 expression is shown for transitional, naive, NCSM, DN and CSM B cell subsets of HC (n = 18) and SCI patients (n = 18), including (s)aSCI (17 samples) and cSCI (29 samples). (E) The concentration of MIF (pg/ml) in the plasma is shown for HC (n = 15) and SCI patients (n = 18), including (s)aSCI (n = 13 samples) and cSCI (n = 15 samples). Mean (bars) ± SD is depicted. Numbers of included samples in each group are also indicated in the first graph of each figure panel. *p < 0.05, **p < 0.01.